Results: Reperfusion treatment was the major methods on non-ST-elevation acutecoronaryinfarction.
结果：再灌注治疗是急性ST段抬高心梗治疗的主要方法。
2
Conclusion: Reperfusion treatment may reduce the mortality of non-ST-elevation acutecoronaryinfarction and the incidence of events in hospital.
结论：再灌注治疗可以降低急性ST段抬高心梗的住院死亡率，减少住院不良事件的发生。
3
CONCLUSIONS in patients with a recent acutecoronary syndrome, rivaroxaban reduced the risk of the composite end point of death from cardiovascular causes, myocardial infarction, or stroke.